Cargando…
Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies
Comprehensive microbiological testing will be a core function of the Pneumonia Etiology Research for Child Health (PERCH) project. The development stage of PERCH provided the time and resources necessary for us to conduct a comprehensive review of the current state of respiratory diagnostics. These...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297547/ https://www.ncbi.nlm.nih.gov/pubmed/22403230 http://dx.doi.org/10.1093/cid/cir1060 |
_version_ | 1782225885787586560 |
---|---|
author | Bhat, Niranjan O'Brien, Katherine L. Karron, Ruth A. Driscoll, Amanda J. Murdoch, David R. |
author_facet | Bhat, Niranjan O'Brien, Katherine L. Karron, Ruth A. Driscoll, Amanda J. Murdoch, David R. |
author_sort | Bhat, Niranjan |
collection | PubMed |
description | Comprehensive microbiological testing will be a core function of the Pneumonia Etiology Research for Child Health (PERCH) project. The development stage of PERCH provided the time and resources necessary for us to conduct a comprehensive review of the current state of respiratory diagnostics. These efforts allowed us to articulate the unique requirements of PERCH, establish that molecular methods would be central to our testing strategy, and focus on a short list of candidate platforms. This process also highlighted critical challenges in the general design and interpretation of diagnostic evaluation studies, particularly in the field of respiratory infections. Although our final molecular diagnostic platform was ultimately selected on the basis of operational and strategic considerations determined by the specific context of PERCH, our review highlighted several conceptual and practical challenges in respiratory diagnostics that have broader relevance for the performance and interpretation of pneumonia research studies. |
format | Online Article Text |
id | pubmed-3297547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32975472013-04-01 Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies Bhat, Niranjan O'Brien, Katherine L. Karron, Ruth A. Driscoll, Amanda J. Murdoch, David R. Clin Infect Dis Supplement Articles Comprehensive microbiological testing will be a core function of the Pneumonia Etiology Research for Child Health (PERCH) project. The development stage of PERCH provided the time and resources necessary for us to conduct a comprehensive review of the current state of respiratory diagnostics. These efforts allowed us to articulate the unique requirements of PERCH, establish that molecular methods would be central to our testing strategy, and focus on a short list of candidate platforms. This process also highlighted critical challenges in the general design and interpretation of diagnostic evaluation studies, particularly in the field of respiratory infections. Although our final molecular diagnostic platform was ultimately selected on the basis of operational and strategic considerations determined by the specific context of PERCH, our review highlighted several conceptual and practical challenges in respiratory diagnostics that have broader relevance for the performance and interpretation of pneumonia research studies. Oxford University Press 2012-04-01 2012-04-01 /pmc/articles/PMC3297547/ /pubmed/22403230 http://dx.doi.org/10.1093/cid/cir1060 Text en © The Author 2012. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Supplement Articles Bhat, Niranjan O'Brien, Katherine L. Karron, Ruth A. Driscoll, Amanda J. Murdoch, David R. Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies |
title | Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies |
title_full | Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies |
title_fullStr | Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies |
title_full_unstemmed | Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies |
title_short | Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies |
title_sort | use and evaluation of molecular diagnostics for pneumonia etiology studies |
topic | Supplement Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297547/ https://www.ncbi.nlm.nih.gov/pubmed/22403230 http://dx.doi.org/10.1093/cid/cir1060 |
work_keys_str_mv | AT bhatniranjan useandevaluationofmoleculardiagnosticsforpneumoniaetiologystudies AT obrienkatherinel useandevaluationofmoleculardiagnosticsforpneumoniaetiologystudies AT karronrutha useandevaluationofmoleculardiagnosticsforpneumoniaetiologystudies AT driscollamandaj useandevaluationofmoleculardiagnosticsforpneumoniaetiologystudies AT murdochdavidr useandevaluationofmoleculardiagnosticsforpneumoniaetiologystudies AT useandevaluationofmoleculardiagnosticsforpneumoniaetiologystudies |